Steven D. Weitman
No más puestos en curso
Perfil
Steven D.
Weitman served as the Chief Medical Officer & Senior Vice President at ILEX Oncology, Inc. and as an Associate Professor at The Medical College of Wisconsin, Inc. and the University of Texas Health Center.
He also served as the Chief Medical Officer at Unibioscreen SA. Weitman holds a doctorate degree from The Medical College of Wisconsin, Inc.
Antiguos cargos conocidos de Steven D. Weitman.
| Empresas | Cargo | Fin |
|---|---|---|
Unibioscreen SA
 Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | Director Técnico/Científico/I+D | 10/05/2011 |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Corporate Officer/Principal | 28/03/2006 |
| University of Texas Health Center | Corporate Officer/Principal | - |
| The Medical College of Wisconsin, Inc. | Corporate Officer/Principal | - |
Formación de Steven D. Weitman.
| The Medical College of Wisconsin, Inc. | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Health Technology |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | Health Technology |
- Bolsa de valores
- Insiders
- Steven D. Weitman